All In MedTech

Device Trial Radar · NCT07902908

Use of a Mandibular Advancement Appliance in Children With Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

25

Planned (sponsor's estimate)

Start

Nov 24, 2026

Primary completion

Jan 1, 2029

Study completion Jan 1, 2030

Sponsor

Sponsor type
NIH
First posted
Oct 29, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 6 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Background: Obstructive sleep apnea (OSA) is a condition where the airway becomes partly or fully blocked during sleep. OSA disrupts normal sleep. In children, if left untreated, OSA can affect development and cause serious health issues. Researchers want to see if a device (DynaFlex Dorsal Accu-fit) worn in the mouth can treat OSA in children. Objective: To test the DynaFlex Dorsal Accu-fit in children with OSA. Eligibility: Children aged 6 to 17 years with mild to moderate OSA. Patients with parents or caregivers that cannot understand and/or speak English will be excluded because this study requires care giver-directed at-home device titration, safety monitoring, weekly reporting, and completion of study questionnaires, and the study materials and standardized procedures are currently available only in English. Patients that are currently using a CPAP appliance and are responding well to the treatment. Design: Participants will have 4 scheduled clinic visits over about 5 months. Participants will be screened. Tests will include an exam of the head, face, jaws, mouth and teeth. Participants will have a three dimensional (3D) low radiation x-ray of the head (CBCT), photos of their teeth and face, and digital 3D dental scan. Their parents or caregivers will answer questions about their sleep and breathing problems. Participants will have one overnight sleep study at the NIH to confirm their OSA diagnosis, unless a sleep study was done recently. During the sleep study, sticky pads with sensors will be placed on their face and body, and small tubes will be placed in the nostrils while they sleep. A parent/caregiver will sleep in the same room. The DynaFlex Dorsal Accu-fit will be custom-made for each participant. The device fits on the teeth and holds the lower jaw in a forward position, opening the airway during sleep. There will be an initial adjustment period of 1 to 4 weeks during which the device is adjusted by the parents/caregivers at home in communication with the study team, and the participant gradually gets comfortable wearing the device during sleep. Parents will download an app to record snoring during this period. After this period, the participants will wear their device every night for 4 months. They will have a clinic visit after the 1st month to make sure that everything is ok, and an end-of-study visit where all the initial tests are going to be repeated, including the sleep study.

Conditions

  • Obstructive Sleep Apnea (OSA)
  • Pediatric Obstructive Sleep Apnea (OSA)
  • Adeno-Tonsillar Hypertrophy
  • Maxillary Hypoplasia
  • Mandibular Hypoplasia
  • Obesity
  • Intraoral Appliance

Interventions

  • DynaFlex Dorsal Accu-FitDevice

    The DynaFlex Dorsal Accu-Fit is an FDA-cleared mandibular advancement appliance for the treatment/management of mild to moderate obstructive sleep apnea (OSA) in adults (K103076). Device labeling and manufacturer instructions describe the DynaFlex Dorsal as a device used for snoring and obstructive sleep apnea and note features intended to support comfort and nightly use, including a two-piece construction that allows some lateral jaw movement and adjustable mandibular advancement.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary objective of this study is to determine the adherence levels, the safety, and the preliminary efficacy of this anterior mandibular repositioning appliance in the management of OSA in children.Time frame: 5 months.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National Institutes of Health Clinical Center

    Bethesda, Maryland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.